General Motors (NYSE: GM) has emerged as a compelling investment opportunity, with Morningstar assigning a fair value estimate of $81 per share, significantly higher than its last traded price of $
Sun Pharmaceutical and Zydus Lifesciences shares could see pressure on Monday as both companies have issued limited recall for some pharmaceutical products in the US market.